Shi Wencai, Wang Heyang, Zheng Xuan, Jiang Xin, Xu Zheng, Shen Hui, Li Min
Military Hygiene Department, Faculty of Naval Medicine, Second Military Medical University, No. 800 Xiangyin Road, Shanghai, 200433, China.
Department of Clinical Nutrition, Changhai Hospital, Second Military Medical University, Shanghai, China.
Biol Trace Elem Res. 2017 Apr;176(2):294-304. doi: 10.1007/s12011-016-0846-5. Epub 2016 Sep 23.
Hepcidin synthesis is reported to be inadequate according to the body iron store in patients with non-alcoholic fatty liver disease (NAFLD) undergoing hepatic iron overload (HIO). However, the underlying mechanisms remain unclear. We hypothesize that hepatocyte nuclear factor-4α (HNF-4α) may negatively regulate hepcidin expression and contribute to hepcidin deficiency in NAFLD patients. The effect of HNF-4α on hepcidin expression was observed by transfecting specific HNF-4α small interfering RNA (siRNA) or plasmids into HepG2 cells. Both direct and indirect mechanisms involved in the regulation of HNF-4α on hepcidin were detected by real-time PCR, Western blotting, chromatin immunoprecipitation (chIP), and reporter genes. It was found that HNF-4α suppressed hepcidin messenger RNA (mRNA) and protein expressions in HepG2 cells, and this suppressive effect was independent of the potential HNF-4α response elements. Phosphorylation of SMAD1 but not STAT3 was inactivated by HNF-4α, and the SMAD4 response element was found essential to HNF-4α-induced hepcidin reduction. Neither inhibitory SMADs, SMAD6, and SMAD7 nor BMPR ligands, BMP2, BMP4, BMP6, and BMP7 were regulated by HNF-4α in HepG2 cells. BMPR1A, but not BMPR1B, BMPR2, ActR2A, ActR2B, or HJV, was decreased by HNF-4α, and HNF4α-knockdown-induced stimulation of hepcidin could be entirely blocked when BMPR1A was interfered with at the same time. In conclusion, the present study suggests that HNF-4α has a suppressive effect on hepcidin expression by inactivating the BMP pathway, specifically via BMPR1A, in HepG2 cells.
据报道,在发生肝脏铁过载(HIO)的非酒精性脂肪性肝病(NAFLD)患者中,根据体内铁储存情况,铁调素的合成不足。然而,其潜在机制仍不清楚。我们推测,肝细胞核因子-4α(HNF-4α)可能对铁调素表达起负调节作用,并导致NAFLD患者铁调素缺乏。通过将特异性HNF-4α小干扰RNA(siRNA)或质粒转染到HepG2细胞中,观察HNF-4α对铁调素表达的影响。通过实时聚合酶链反应(PCR)、蛋白质免疫印迹法、染色质免疫沉淀(chIP)和报告基因检测HNF-4α对铁调素调节的直接和间接机制。结果发现,HNF-4α抑制HepG2细胞中铁调素信使核糖核酸(mRNA)和蛋白质表达,且这种抑制作用独立于潜在的HNF-4α反应元件。HNF-4α使SMAD1而非STAT3的磷酸化失活,并且发现SMAD4反应元件对HNF-4α诱导的铁调素减少至关重要。在HepG2细胞中,抑制性SMAD蛋白(SMAD6和SMAD7)以及骨形态发生蛋白受体(BMPR)配体(BMP2、BMP4、BMP6和BMP7)均不受HNF-4α调节。HNF-4α使骨形态发生蛋白受体1A(BMPR1A)而非骨形态发生蛋白受体1B(BMPR1B)、骨形态发生蛋白受体2(BMPR2)、激活素受体IIA(ActR2A)、激活素受体IIB(ActR2B)或血色素沉着症相关蛋白(HJV)减少,并且当同时干扰BMPR1A时,HNF4α基因敲低诱导的铁调素刺激可被完全阻断。总之,本研究表明,在HepG2细胞中,HNF-4α通过使骨形态发生蛋白(BMP)信号通路失活,特别是通过BMPR1A,对铁调素表达具有抑制作用。